HAE stock

Haemonetics Corporation (HAE) earnings · rev $1.33B

These earnings events as JSON? API free 100/day

Haemonetics Corporation (HAE) is a medical devices company listed on US.

This HAE earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.

Latest reported HAE revenue for 2026-03-28 was $1.33B. Net income was $97.3M. Revenue was down 2.0% from 2025-03-29 to 2026-03-28. HAE currently screens at market cap $3.24B.

When the next HAE 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.

The change that matters: Revenue was down 2.0% from 2025-03-29 to 2026-03-28. An earnings headline that ignores that move is noise.

Not investment advice. Full HAE research stays on the stock page; the tape stays on the quote page.

HAE earnings FAQ

What are HAE's latest revenue and net income?

Latest cached Haemonetics Corporation (HAE) revenue for Mar 28, 2026 was $1.33B. Net income was $97.3M. Statements: https://lician.com/financials/hae

What is HAE's latest diluted EPS?

Latest cached Haemonetics Corporation (HAE) diluted EPS for Mar 28, 2026 was $2.05.

What period does the latest HAE earnings print cover?

The latest cached Haemonetics Corporation (HAE) earnings print covers Mar 28, 2026. The prior cached period on this page is Mar 29, 2025.

How did HAE revenue change from the prior cached period?

Cached Haemonetics Corporation (HAE) revenue was down 2.0% from $1.36B (Mar 29, 2025) to $1.33B (Mar 28, 2026). Statements: https://lician.com/financials/hae

Where are HAE earnings listed?

Cached earnings facts for Haemonetics Corporation (HAE) are listed at https://lician.com/earnings/hae. Statements: https://lician.com/financials/hae

Not investment advice.

Full HAE analysis